ANAPLEX

Main information

  • Trade name:
  • ANAPLEX ANABOLIC HORMONE AND VITAMIN COMPLEX TABLETS
  • Pharmaceutical form:
  • ORAL TABLET
  • Units in package:
  • 100Tab
  • Class:
  • Veterinary Medicine
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • ANAPLEX ANABOLIC HORMONE AND VITAMIN COMPLEX TABLETS
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • CAT | DOG | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | KITTEN | PUPPY
  • Therapeutic area:
  • hormone,vitamins
  • Therapeutic indications:
  • ANABOLIC STEROID | VITAMIN | ABORTION THREAT | ANDROGENIC PROPERTIES | BIOTIN DEFICIENCIES | BONE REPAIR | CATABOLIC COMPLICATIONS | CONVALESCENCE | DETOXIFYING AGENT | ERYTHROPOIETIC ACTIVITY | GERIATRIC THERAPY | IMPROVE APPETITE | MALE SEXUAL CHARACTERISITICS | MUSCLE DEVELOPMENT | NON-VIRILISING ANABOLIC | PATHOPHYSIOLOGICAL PROCESS | PROTEIN AND MINERAL ANABOLIC | SKELETAL CONDITIONS | STAMINA | TISSUE BREAKDOWN | TISSUE REPAIR | VIRILISING ANABOLIC | VITAMIN A | VITAMIN B | VITAMIN C | VITAMIN D | VITAMIN DEFICIENCIES | VITAMIN E | VITAMIN K
  • Product summary:
  • For use as a supplement in post-surgical convalescence, geriatrics and for stimulating erythropoietic activity in dogs and cats.Duration of treatment should be determined under the advice of a veterinary surgeon.

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Registered and available
  • Authorization number:
  • 36178/56591
  • Authorization date:
  • 06-08-2012
  • Last update:
  • 15-06-2017

Patient Information leaflet: composition, indications, side effects, dosage, interactions, adverse reactions, pregnancy, lactation

ANAPLEX Tablets (ANZ)

May12

page 1/1

Immediate container main panel

PRESCRIPTION ANIMAL REMEDY

KEEP OUT OF REACH OF CHILDREN

FOR ANIMAL TREATMENT ONLY

ANAPLEX

Anabolic Hormone and Vitamin Complex Tablets

Each tablet contains

5.0 mg Norethandrolone

4500 1U Retinyl Acetate (Vitamin A)

1.0 mg di-alpha Tocopheryl Acetate (Vitamin E)

450 IU Cholecalciferol (Vitamin D)

20.0 mg Ascorbic acid (Vitamin C)

5.0 mg Nicotinamide

1.5 mg Thiamine Hydrochloride

1.5 mg Calcium Pantothenate

5.0 mg Di-lsopropylamine dichloroacetate

Approved

0.2 mg Pyridoxine hydrochloride

0.67 mg Riboflavine

5.0 mg Methionine

1.0 mg Thioctic acid'

45.9 mg Calcium

10.26 mg Magnesium

44.1 mg Phosphorus

For use as a supplement in post-surgical convalescence, geriatrics, and for stimulating erythropoietic activity

in dogs and cats.

100 Tablets

[Jurox logo]

Immediate container ancillary panel

DIRECTIONS FOR USE:

PRECAUTIONS: Androgens

can induce masculinisation of a female foetus and may have a

suppressive effect on sexual development in young male animals.

DOSAGE AND ADMINISTRATION:

For oral treatment only.

Dogs and Cats: 1 tablet per 10 kg bodyweight daily. Duration of treatment should be deterinined under the

advice of a veterinary surgeon.

FIRST AID: If poisoning occurs, contact a doctor or Poisons Information Centre. Phone Australia

131126; New Zealand 0800 764 766.

Jurox Pty Limited

85 Gardiner Street, Rutherford NSW 2320, Australia

Infoline 1800 023 312

APVMA 36178156591

Dispose of empty container by wrapping with paper and placing in garbage

STORE below 30°C (Room Temperature)

Exp:

[Item code]

Infopest

Verified

13-11-2018

Oscor Inc. Issues Recall Product Expansion of TB – Temporary Bipolar Pacing Lead (Unshrouded 2 mm Pins Models)

Oscor Inc. Issues Recall Product Expansion of TB – Temporary Bipolar Pacing Lead (Unshrouded 2 mm Pins Models)

On September 26, 2018 Oscor notified customers of a recall for certain lots (Recall No. 1035166- 09/07/2018-01-R) of TB Unshrouded Bipolar Pacing Leads. As part of the recall correction activities, Oscor is retrieving any remaining inventory out in the field. The recall scope is being expanded to include expired inventory for devices distributed between December 21, 2011 to May 17, 2018. The recall expansion is to ensure proper disposition of expired units. The FDA has been notified and is aware Oscor In...

FDA - U.S. Food and Drug Administration

9-11-2018

Safety assessment of the substance Ln 1,4‐benzene dicarboxylic acid (with Ln = La, Eu, Gd, Tb) for use in food contact materials

Safety assessment of the substance Ln 1,4‐benzene dicarboxylic acid (with Ln = La, Eu, Gd, Tb) for use in food contact materials

Published on: Wed, 07 Nov 2018 00:00:00 +0100 The EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP Panel) assessed the safety of the additive Ln 1,4‐benzene dicarboxylic acid (with Ln = La, Eu, Gd, Tb) for use in food contact materials. It is a family of mixtures combining the four lanthanides lanthanum (La), europium (Eu), gadolinium (Gd) and/or terbium (Tb) in different proportions as their 1,4‐benzene dicarboxylate complexes, used as a taggant in plastics for authentication and ...

Europe - EFSA - European Food Safety Authority Publications

27-9-2018

Oscor Inc. Issues Recall of TB – Temporary Bipolar Pacing Lead (Unshrouded 2 mm Pins Models)

Oscor Inc. Issues Recall of TB – Temporary Bipolar Pacing Lead (Unshrouded 2 mm Pins Models)

During the use of some TB - Temporary Bipolar Pacing Leads, featuring the 2mm unshrouded connectors, the connector cap housing (see Picture 1, No. 2 Pin Cap and Cover) may slide and potentially expose the connection wire. In some instances, this may cause the wire to be more susceptible to loss of connectivity or breakage during movement of the cables causing interruption of the pacing system. The analysis of the returned devices attributed the failure to a design change of the cap housing of the pins. ...

FDA - U.S. Food and Drug Administration

23-11-2018

.@US_FDA issues Class I Medical Device Recall, the most serious type of   recall: Oscor Recalls TB Temporary Bipolar Pacing Leads Due to  Connector Separation Causing Potential for Loss of Pacing. Find out  more:  https://go.usa.gov/xPHxF  #FDA #MedicalDe

.@US_FDA issues Class I Medical Device Recall, the most serious type of recall: Oscor Recalls TB Temporary Bipolar Pacing Leads Due to Connector Separation Causing Potential for Loss of Pacing. Find out more: https://go.usa.gov/xPHxF  #FDA #MedicalDe

. @US_FDA issues Class I Medical Device Recall, the most serious type of recall: Oscor Recalls TB Temporary Bipolar Pacing Leads Due to Connector Separation Causing Potential for Loss of Pacing. Find out more: https://go.usa.gov/xPHxF  #FDA #MedicalDevice pic.twitter.com/negJ6HU4x2

FDA - U.S. Food and Drug Administration